GlassScriptPhysician profile
Lukas Foster
NPI 1053949636
$7,371.14
in general payments reported to CMS, 2019-2025
9 companies · $6,322 in 2025
The $6,322 reported for 2025 was more than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $214 · 2023: $348 · 2024: $487 · 2025: $6,322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $5,000 · Food and Beverage: $2,001 · Travel and Lodging: $156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $5,000.00 |
| Food and Beverage | $2,001.22 |
| Travel and Lodging | $155.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $5,000.00 | 2025 | |
| Stryker Corporation | $1,437.02 | 2022-2025 | Axsos, Pangea, Gamma |
| Globus Medical, INC. | $401.69 | 2024-2025 | Anthem, Autobahn, Evo Retrograde |
| Baxter Healthcare | $138.44 | 2025 | Actifuse, Tisseel, Floseal |
| Depuy Synthes Sales INC. | $137.99 | 2025 | Na, Lcp |
| Osteoremedies, LLC | $90.04 | 2025 | Xperience |
| Bone Support INC. | $75.66 | 2025 | Ceramentbone Void Filler, Cerament G |
| Medical Device Business Services, INC. | $72.90 | 2024 | |
| Si-Bone, INC. | $17.40 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lukas Foster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.